Company
(symbol)#*

Date filed

Shares/units (M)

Price

Shares out@

Lead, other underwriters

Gross (US$M)

INITIAL OFFERINGS

Abivax SA (Paris; Euronext:ABVX)1

6/8/15

2S

€18.26 - €24.34

N/A

N/A

$49

Acacia Pharma Ltd. (London; LSE)

9/15/15

N/A

N/A

N/A

N/A

£150 (US$231)

Aclaris Therapeutics Inc. (Malvern, Pa.; ACRS)

8/19/15

N/A

N/A

N/A

Jefferies; Citigroup; William Blair

$86.25

Advanced Inhalation Therapies Ltd. (Tel Aviv, Israel; AITP)

8/27/15

N/A

N/A

N/A

N/A

$36

Altheadx Inc. (San Diego; IDGX)

12/23/14

N/A

N/A

17.9

Citigroup (co-lead); Jefferies (co-lead); William Blair; Cantor Fitzgerald

$69

Anaptysbio Inc. (San Diego; ANAB)

9/9/15

N/A

N/A

N/A

BMO Capital Markets (co-lead); Stifel Nicolaus & Co. (co-lead); JMP Securities; Wedbush Securities

$86.25

Anterios Inc. (New York; ANTE)

4/2/15

3.9S

$12-$14

N/A

Stifel (co-lead); RBC Capital Markets (co-lead); JMP Securities; Needham & Co.

$50.7

Biocardia Inc. (San Carlos, Calif.; BCDA)

6/16/15

N/A

N/A

N/A

Cantor Fitzgerald (co-lead); Roth Capital Partners (co-lead); Maxim Group

N/A

Cerecor Inc. (Baltimore; CERC)2

9/8/15

4.23S

$6-$7

8.86

Maxim Group (lead); Laidlaw & Co. (UK) Ltd.

$27.5

Clarus Therapeutics Inc. (Northbrook, Ill.; CLRS)

5/23/14

N/A

N/A

N/A

Citigroup (co-lead); Credit Suisse (co-lead); Canaccord Genuity; Needham & Co.

$86.25

Cytomx Therapeutics Inc. (South San Francisco; CTMX)

9/1/15

6.7S

$14-$16

N/A

BofA Merrill Lynch (co-lead); Jefferies (co-lead); Cowen and Co. (co-lead); Oppenheimer & Co.

$100.5

Dimension Therapeutics Inc. (Cambridge, Mass.; DMTX)

9/14/15

N/A

N/A

N/A

Goldman, Sachs & Co. (co-lead); Citigroup (co-lead); Wells Fargo Securities (co-lead); Canaccord Genuity; Cantor Fitzgerald & Co.

$115

Edge Therapeutics Inc. (Berkeley Heights, N.J.; EDGE)

8/18/15

5.67S

$14-$16

27

Leerink Partners (co-lead); Credit Suisse (co-lead)

$104

Eyegate Pharma Inc. (Waltham, Mass.; OTCQB:EYEG)3

7/31/14

0.833S

$6

6.94

Aegis Capital (co-lead); Chardan Capital Markets (co-lead)

$5

Faron Pharmaceuticals Oy (Turku, Finland; AIM)

9/9/15

N/A

N/A

N/A

N/A

£20 (US$30.5)

Gelesis Inc. (Cambridge, Mass.; GLSS)

4/1/15

4S

$12-$14

N/A

Piper Jaffray (co-lead); Stifel (co-lead); Guggenheim Securities (co-lead)

$52

Gensight Biologics SA (Paris; GNST)

7/7/15

ADS

N/A

N/A

Leerink (co-lead); Evercore ISI (co-lead); Canaccord Genuity (co-lead)

$100

Lumena Pharmaceuticals Inc. (San Diego; LIVR)

4/2/14

N/A

N/A

N/A

Citigroup (co-lead); Cowen and Co. (co-lead); Leerink Partners (co-lead)

$75

Mirna Therapeutics Inc. (Austin, Texas; MIRN)4

8/26/15

4.65S

$13-$15

N/A

Citi; Leerink Partners

$65

Myokardia Inc. (South San Francisco; MYOK)

9/30/15

N/A

N/A

N/A

Credit Suisse (co-lead); Cowen and Co. (co-lead); BMO Capital Markets; Wedbush Securities

$86.3

Oasmia Pharmaceutical AB (Uppsala, Sweden; OASM)5

7/8/15

N/A

ADS

N/A

Ladenburg Thalmann (lead)

$23

Oncore Biopharma Inc. (Doylestown, Pa.)6

11/25/14

N/A

N/A

N/A

N/A

N/A

Revo Biologics Inc. (Framingham, Mass.; RBIO)7

6/25/14

3.6S

$13-$15

18.4

Piper Jaffray (co-lead); Guggenheim Securities (co-lead); Roth Capital Partners; BTIG

$50.4

Samsung Bioepsis (South Korea; joint venture of Samsung Biologics and Biogen Inc., of Cambridge, Mass.)

8/24/15

N/A

N/A

N/A

N/A

KRW1.5T (US$1.3B)

Sancilio Pharmaceuticals Inc. (Riviera Beach, Fla.; SPCI)

9/2/15

N/A

N/A

N/A

N/A

$86.25

Shield Therapeutics Ltd. (LSE)

9/9/15

N/A

N/A

N/A

N/A

£110 (US$168)

Silenseed Ltd. (Jerusalem; RNAI)

6/18/14

N/A

N/A

N/A

Aegis Capital (lead)

$36.4

Strongbridge Biopharma plc (formerly Cortendo AB, Trevose, Pa.; SBBP)8

9/1/15

4.25S

N/A

N/A

BofA Merrill Lynch (co-lead); Stifel (co-lead); JMP Securities; Roth Capital Partners; Arctic Securities

$87.6

Vtv Therapeutics Inc. (High Point, N.C.; VTVT)9

6/15/15

7.8S

$15-$17

N/A

Piper Jaffray & Co. (co-lead); Stifel; Nicolaus & Co. (co-lead); Canaccord Genuity; Janney Montgomery Scott

$172.5